Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-07

Clinical Trial Update: Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of TPN171H tablets for erectile dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TPN171H

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED